Proteomic Biomarker Analytics Market: By Application, Clinical Diagnostics, Others), By Technology, By End User and Geography
Proteomic Biomarker Analytics Market size was valued at US$ 24,983.8 million in 2023 and is poised to grow at a CAGR of 9.1% from 2024-2030. Proteomic biomarkers are proteins that detect the presence of certain illnesses or processes. They serve as quantitative markers of normal biological processes, pathogenic processes, or pharmacologic responses to therapeutic treatments such as tumour detection and treatment. This technology has the potential to replace Genomics and become the centre point of therapeutic applications. As we have discussed its potential application there is a huge opportunity for companies to tap in. Developments in Protein Biomarkers give a huge potential to the companies to expand in disease diagnostics etc.
The increasing incidence of chronic illnesses, growing demand for personalized medicines, increasing R&D expenditure and advancement of diagnostic techniques are driving the growth of the proteomics industry. The rising frequency of chronic illnesses such as cardiovascular diseases, respiratory diseases and especially cancer has increased the need for an effective diagnostic method. Furthermore, the increasing use of proteomics in drug discovery and development has greatly boosted market growth. The main restraints for this market are the lack of skilled workers who has expertise in proteomic research, cost and the huge requirement of resources, infrastructure needed in the research. There are regulatory norms which are also very stringent and acts as restraints. COVID-19 was a push of the Proteomic biomarker analytics market as most of the companies and research institutes invested in proteomic technology to find the relevant biomarkers for COVID-19.
Study Period
2024-2030Base Year
2023CAGR
9.1%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Drug discovery sees a trend of using proteomic technology, and finding of disease specific biomarkers signify the rise of usage of biomarkers in diagnostics. Major companies are investing huge in technologies in discovery of biomarkers such as Mass spectrometry and protein microarrays. The main research topic in this market is the early diagnostics of cancer. All these factors addition to advancement of healthcare gives a upside drive to the market. There are hundreds of clinical trials of protein biomarkers only for cancer, which indicates the involvement of companies in research. From this we can conclude that the demand for the new and existing Proteomic Biomarkers will be rising and this helps the market to expand. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Illumina, Inc., Merck, Thermo Fisher Scientific holds a substantial share of the Proteomic biomarker analytics market.
North America dominates the Global Proteomic biomarker analytics market and is expected to dominate in the forecasted years because of its advanced infrastructure and increased ability to spend on research. The National Institutes of Health (NIH) of the U.S. provided $37 billion for biomedical research, which also includes Proteomic Biomarker Identification. Germany is the lucrative and most dynamic market in Europe, which contributes significant share in the Europe Proteomic biomarker analytics market. In Asia Pacific, Japan is the dominant player of the Proteomic biomarker analytics market which holds more than half of the market share.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 24,983.8 million |
|
Market CAGR |
9.1% |
|
By Application |
|
|
By Technology |
|
|
By End User |
|
Download Free Sample Report
Proteomic biomarker analytics market size was valued at US$ 24,983.8 million in 2023 and is poised to grow at a CAGR of 9.1% from 2024-2030.
The key players in the proteomic biomarker analytics market Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Illumina, Inc., Merck, Thermo Fisher Scientific holds a substantial share of the Proteomic biomarker analytics market.
The increasing incidence of chronic illnesses mainly cancer, growing demand for personalized medicines, increasing R&D expenditure and advancement of diagnostic techniques are driving the growth of the proteomics industry.
Asia Pacific is estimated to be the fastest growing region for the Proteomic biomarker analytics market
North America has the largest share in the Proteomic biomarker analytics market.
| 1.Executive Summary |
| 2.Global Proteomic Biomarker Analytics Market Introduction |
| 2.1.Global Proteomic Biomarker Analytics Market - Taxonomy |
| 2.2.Global Proteomic Biomarker Analytics Market - Definitions |
| 2.2.1.Application |
| 2.2.2.Technology |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Proteomic Biomarker Analytics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Proteomic Biomarker Analytics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Proteomic Biomarker Analytics Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Drug discovery |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Research Application (cancer) |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Clinical Diagnostics |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Other |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Proteomic Biomarker Analytics Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Mass Spectrometry |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. ELISA/Beads |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Hybrid Multiplex |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. X-ray Crystallography |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Electrophoresis |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Microarray |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Other |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7.Global Proteomic Biomarker Analytics Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Academic and Research institutions |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharma/biotech Companies |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Clinical diagnostic laboratories |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Other |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Proteomic Biomarker Analytics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Drug discovery |
| 9.1.2.Research Application (cancer) |
| 9.1.3.Clinical Diagnostics |
| 9.1.4.Other |
| 9.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Mass Spectrometry |
| 9.2.2.ELISA/Beads |
| 9.2.3.Hybrid Multiplex |
| 9.2.4.X-ray Crystallography |
| 9.2.5.Electrophoresis |
| 9.2.6.Microarray |
| 9.2.7.Other |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Academic and Research institutions |
| 9.3.2.Pharma/biotech Companies |
| 9.3.3.Clinical diagnostic laboratories |
| 9.3.4.Other |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drug discovery |
| 10.1.2.Research Application (cancer) |
| 10.1.3.Clinical Diagnostics |
| 10.1.4.Other |
| 10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Mass Spectrometry |
| 10.2.2.ELISA/Beads |
| 10.2.3.Hybrid Multiplex |
| 10.2.4.X-ray Crystallography |
| 10.2.5.Electrophoresis |
| 10.2.6.Microarray |
| 10.2.7.Other |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Academic and Research institutions |
| 10.3.2.Pharma/biotech Companies |
| 10.3.3.Clinical diagnostic laboratories |
| 10.3.4.Other |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drug discovery |
| 11.1.2.Research Application (cancer) |
| 11.1.3.Clinical Diagnostics |
| 11.1.4.Other |
| 11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Mass Spectrometry |
| 11.2.2.ELISA/Beads |
| 11.2.3.Hybrid Multiplex |
| 11.2.4.X-ray Crystallography |
| 11.2.5.Electrophoresis |
| 11.2.6.Microarray |
| 11.2.7.Other |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Academic and Research institutions |
| 11.3.2.Pharma/biotech Companies |
| 11.3.3.Clinical diagnostic laboratories |
| 11.3.4.Other |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Drug discovery |
| 12.1.2.Research Application (cancer) |
| 12.1.3.Clinical Diagnostics |
| 12.1.4.Other |
| 12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Mass Spectrometry |
| 12.2.2.ELISA/Beads |
| 12.2.3.Hybrid Multiplex |
| 12.2.4.X-ray Crystallography |
| 12.2.5.Electrophoresis |
| 12.2.6.Microarray |
| 12.2.7.Other |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Academic and Research institutions |
| 12.3.2.Pharma/biotech Companies |
| 12.3.3.Clinical diagnostic laboratories |
| 12.3.4.Other |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Proteomic Biomarker Analytics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Drug discovery |
| 13.1.2.Research Application (cancer) |
| 13.1.3.Clinical Diagnostics |
| 13.1.4.Other |
| 13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Mass Spectrometry |
| 13.2.2.ELISA/Beads |
| 13.2.3.Hybrid Multiplex |
| 13.2.4.X-ray Crystallography |
| 13.2.5.Electrophoresis |
| 13.2.6.Microarray |
| 13.2.7.Other |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Academic and Research institutions |
| 13.3.2.Pharma/biotech Companies |
| 13.3.3.Clinical diagnostic laboratories |
| 13.3.4.Other |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Abbott Laboratories |
| 14.2.2.Agilent/Dako |
| 14.2.3.Basepair Biotechnologies |
| 14.2.4.Beckman Coulter Diagnostics |
| 14.2.5.Becton, Dickinson and Company |
| 14.2.6.Bio-Rad Laboratories, Inc. |
| 14.2.7.Bruker |
| 14.2.8.C2N Diagnostics |
| 14.2.9.Cepheid (Danaher) |
| 14.2.10.Eve Technologies |
| 14.2.11.Fluidic Analytics |
| 14.2.12.Fujirebio |
| 14.2.13.Hybrigenics Services |
| 14.2.14.Luminex Corp |
| 14.2.15.Nautilus Biotechnology |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
